Cancer’s secret safety net
Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.
Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.
Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.
Time and again, an unassuming roundworm has illuminated aspects of biology with major consequences for human health.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
New research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.
MIT community members made headlines with key research advances and their efforts to tackle pressing challenges.
The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
A study profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking a treatment-resistant and deadly brain cancer.
New findings may help researchers identify genetic mutations that contribute to rare diseases, by studying when and how single genes produce multiple versions of proteins.
Inspired by traditional acupuncture, the approach has potential to impact all implantable bioelectronic devices, enabling applications such as hypertension mitigation.
MIT engineers show they can accurately measure blood glucose by shining near-infrared light on the skin.
BoltzGen generates protein binders for any biological target from scratch, expanding AI’s reach from understanding biology toward engineering it.
The approach could transform large-scale biomanufacturing by enabling automated and contamination-conscious workflows for cell therapies, tissue engineering, and regenerative medicine.
Five volunteers received 40Hz stimulation for around two years after an early-stage clinical study. Those with late-onset Alzheimer’s performed better on assessments than Alzheimer’s patients outside the trial.